A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: loaded (95), weighed down (29), burdened (63)

InP RCODOX M(66) cyclophosphamide doxorubicin methotrexate rituximab vincristine

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-METHOTREXATE-RITUXIMAB-VINCRISTINE (RCODOX-M) 66 years and above Inpatient Regimen There are multiple versions of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RCODOX-M66-cyclophosphamide-doxorubicin-methotrexate-rituximab-vincristine.pdf

InP RCODOX M(65) cyclophosphamide doxorubicin methotrexate rituximab vincristine

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-METHOTREXATE-RITUXIMAB-VINCRISTINE (RCODOX-M) 65 years and below Inpatient Regimen There are multiple versions of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RCODOX-M65-cyclophosphamide-doxorubicin-methotrexate-rituximab-vincristine.pdf

Ferinject - patient information

Description
Ferinject is special type of iron preparation given through a drip into a vein (also known as an 'infusion'). Ferinject is
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Ferinject.pdf

Ferinject (gynaecology) - patient information

Description
This factsheet explains what Ferinject is, what the treatment involves and what the possible side effects are.
Url
/Media/UHS-website-2019/Patientinformation/Womenshealth/Ferinject-gynaecology-patient-information.pdf

HSCT Amb Melphalan-Bortezomib SC

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT AUTOGRAFT AMBULATORY MELPHALAN and BORTEZOMIB SC Multiple Myeloma This regimen will only be available to prescribe at
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCT-Amb-Melphalan-Bortezomib-SC-Ver1.pdf

HSCT AmB Melphalan

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT AUTOGRAFT AMBULATORY MELPHALAN (200mg/m2) Multiple Myeloma This regimen will only be available to prescribe at units
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCT-AmB-Melphalan.pdf

InP cytarabine methotrexate

Description
Chemotherapy Protocol LYMPHOMA CYTARABINE-METHOTREXATE Inpatient Regimen Regimen • Lymphoma – InP-Cytarabine-Methotrexate Indication • Non-Hodgkin’s Lymphoma (CNS disease) Toxicity Drug
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-cytarabine-methotrexate.pdf

InP-PAM-(cycles 5-6) v1

Description
Chemotherapy Protocol Sarcoma DOXORUBICIN-METHOTREXATE (cycles 5-6) Inpatient Regimen There are multiple versions of this protocol in use. Please ensure
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-PAM-cycles-5-6-v1.pdf

HSCTMelphalan-Bortezomib IV

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT AUTOGRAFT InP - MELPHALAN and BORTEZOMIB (IV) Please confirm correct protocol with transplant schedule Regimen • HSCT – InP - Melphalan
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTMelphalan-Bortezomib-IV.pdf

HSCTMelphalan 200mg/m²

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT AUTOGRAFT MELPHALAN (200mg/m2) Multiple Myeloma This regimen will only be available to prescribe at units which
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTMelphalan-200mg-m².pdf
11 to 20 of 38
Previous 1 2 3 4 Next